As of 2025-07-07, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (15.75) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -475.9%.
The range of the Relative Valuation is (15.34) - (18.84) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 13.8x | 9.0x |
| Forward P/E multiples | 11.2x - 17.8x | 14.0x |
| Fair Price | (15.34) - (18.84) | (15.75) |
| Upside | -466.1% - -549.7% | -475.9% |
| Date | P/E |